We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shire | LSE:SHP | London | Ordinary Share | JE00B2QKY057 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 4,690.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
21/8/2015 14:02 | the baxalta news was not generally well received. It appears that shire are desperate not to be taken over and are doing everything in their power to avoid it whether detrimental to shareholders or not. I dont like the baxalta deal at all. | pyemckay | |
21/8/2015 13:50 | Open your eyes, NOTHING is holding up well. | gbb483 | |
21/8/2015 12:14 | Share price not holding up well could scupper the offer or massive dilution | mellorscarthwaite | |
07/8/2015 14:34 | Thing is,hostile bids in the pharmaceutical industry can be counterproductive.Th | steeplejack | |
07/8/2015 09:48 | Why has Shire joined the biotech bonanza with Baxalta bid? The sector is awash with mergers and acquisitions but it’s hard to understand what the appeal of Shire/Baxalta is meant to be | zho | |
07/8/2015 09:38 | The Wall Street Journal has questioned whether Shire isn't displaying blind faith in bidding for Baxalta having not done the necessary full due diligence.Additional Anyway,recent selling of the ADRs suggests that there's some scepticism the other side of the water.Biotechs in general took a hammering last night in the U.S. | steeplejack | |
05/8/2015 09:44 | That's history. | gbb483 | |
05/8/2015 09:42 | Less than a year on from AbbVie, there's a delicious irony to Shire's $30bn bid for Baxalta Flemming Ornskov's approach for the newly created Baxalta is the Anglo-Irish drugmaker's biggest ever takeover to date | zho | |
05/8/2015 08:19 | Shire launches $30bn unsolicited all share bid for US rival Baxalta Shire reveals proposal to merge American rival Baxalta as part of chief executive Flemming Ornskov's plan to generate $10bn of revenues by 2020 | zho | |
04/8/2015 18:50 | This move on Baxalta is ambitious and amongst other things is probably guaranteed to wind up the American legislators including a President who is anti the "arbitraging" of differing national corporate tax rates.Yet,it's clearly been well considered by Shire.The opportunity to achieve massive margin improvements at Baxalta (only just out of the gate) is just too tempting and they've even thought about mopping up the inevitable wash back of stock that will occur if the bid goes through.One can only trust the Shire management that they've crunched their numbers but I can't help thinking this could prove a political hornet's nest....but if they succeed and they don't put everyone's noses out of joint,all good and well. | steeplejack | |
08/6/2015 10:18 | More financing if this goes through. It concerns me how fast these guys are trying to grow. | pyemckay | |
08/6/2015 08:50 | The markets obviously aren't too keen on that idea. | gbb483 | |
07/6/2015 19:57 | Interesting: | jimbobjames2002 | |
07/5/2015 10:47 | Perhaps at steeplejack suggest, it could be a healthy correction. It had been on a strong run since Oct 14, rising from £37 to c. £55 in six months, c. 50% gain. I'm guessing many are banking gains. The outlook remains positive, but mid single digit EPS growth this FY perhaps doesn't excite the momentum crowd who appear to be making an exit. It'll be interesting to know where it finds support. I'm not a chartist, so I'll leave that guess to someone with expertise. GL. | futurdoc | |
07/5/2015 10:37 | Any idea why we keep dropping. I thought the results were well received. | gardener8 | |
02/4/2015 13:30 | Healthy correction? | steeplejack | |
02/4/2015 13:21 | Begining to look like the rally is over. Time to get out? | gbb483 | |
27/3/2015 17:36 | Shire is among the day’s risers in a downbeat market after a broker upgrade, and despite suggestions it could be planning another big deal. | zho | |
12/3/2015 11:22 | Ex-Div today and still the share price is positive (though to be honest, the dividend is pretty insignificant compared to the daily price movement). | gbb483 | |
10/3/2015 10:51 | Quieter the better IMO - under the radar is often the most lucrative way. Some of my best performers have very quiet threads. | jimbobjames2002 | |
10/3/2015 09:44 | Shire.. Very quiet board for well performing share.. Why?_____Oxus Gold in arbitration against Uzbekistan. High risk, possible high returns. News expected any day | marmar80 | |
15/2/2015 12:35 | Its just an automatic post - happens with any stock mentioned in the podcast - Zak Mir reckoned from the chart that the share price could go to £55. | jimbobjames2002 | |
14/2/2015 22:21 | JeffCranbounre 14 Feb'15 - 15:24 - 139 of 140 0 0 (Filtered) This idiot needs banning | gbb483 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions